South Africa Diabetes Drugs and Devices Market Size (2024 - 2029)

The market size for diabetes care drugs and devices in South Africa is projected to experience growth over the forecast period. The COVID-19 pandemic has positively influenced this market expansion, as the intersection of diabetes and COVID-19 has highlighted the need for improved blood glucose management. The increasing prevalence of diabetes, driven by factors such as obesity and sedentary lifestyles, is contributing to the market's growth. Additionally, the adoption of advanced insulin delivery systems and technological innovations by leading manufacturers are further propelling the market's expansion.

Home Market Analysis Healthcare Research Device Drug Combination Research South Africa Diabetes Drugs and Devices Market Market Size

Market Size of South Africa Diabetes Drugs and Devices Industry

South Africa Diabetes Drugs And Devices Market Summary
Study Period 2018 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2018 - 2022
CAGR 2.00 %

Major Players

South Africa Diabetes Drugs and Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

South Africa Diabetes Drugs and Devices Market Analysis

South Africa's diabetes care drugs and devices market size was estimated at USD 0.47 billion in the current year. The market is expected to reach USD 0.55 billion in five years, registering a CAGR of more than 2% during the forecast period.

The COVID-19 pandemic positively impacted the Diabetes Drugs market growth in South Africa. Patients with diabetes infected with COVID-19 may journey to improved blood glucose, abnormal glucose variability, and diabetic complications. The prevalence of diabetes in human beings with COVID-19 induced a good-sized increase in severity and mortality of COVID-19 in people with either kind 1 (T1DM) or kind two diabetes mellitus (T2DM), particularly in affiliation with terrible glycemic control. While new-onset hyperglycemia and new-onset diabetes (both T1DM and T2DM) have been increasingly diagnosed in the context of COVID-19 and have been associated with worse outcomes. A patient's blood glucose must be monitored and managed regularly to avoid aggravation.

According to IDF Diabetes Atlas 2022, one in nine adults in South Africa live with diabetes. The principal analysis for people living with diabetes is imbalances in blood glucose levels, which do not comply with the general blood glucose levels. The customary lab diagnostic tests can only help to diagnose the sickness by physicians. Patients with more fluctuations in glucose stages want to get it checked daily. Patients administering insulin must frequently test their blood glucose stages, adjust their insulin doses, or change the medication if necessary. The rate of newly diagnosed Type 1 and Type 2 diabetes cases is considered to increase, normally due to obesity, unhealthy diet, and bodily inactivity. The swiftly increasing incidence and incidence of diabetic sufferers and healthcare expenditure in developed international locations are warning signs of the growing usage of diabetic care products. Moreover, the growing adoption of insulin transport units and the rising incidence of diabetes is riding the market growth. Leading producers are focusing on technological innovations and developing superior products to acquire a sizeable market share.

Therefore, owing to the aforementioned factors, the studied market is anticipated to grow over the analysis period.

South Africa Diabetes Drugs and Devices Industry Segmentation

Patients with type 1 diabetes need to be given insulin because their pancreas cannot process it. To control blood glucose levels, insulin must be given various times daily. Some individuals with type 2 diabetes also have to take antidiabetic drugs. These drugs include diabetes medications and injections, for example, insulin. The South Africa diabetes care drugs and devices market is segmented by drugs (insulin, oral anti-diabetic drugs, non-insulin injectable drugs, and combination drugs) and devices (management devices such as insulin pumps, insulin pens, syringes, cartridges, and jet injectors, and monitoring devices including self-monitoring blood and continuous glucose monitoring). The report offers the value (in USD) and volume (in unit) for the above segments.

Devices
Monitoring Devices
Self-monitoring Blood Glucose Devices
Continuous Blood Glucose Monitoring
Management Devices
Insulin Pump
Insulin Syringes
Insulin Cartridges
Disposable Pens
Drugs
Oral Anti-Diabetes Drugs
Insulin Drugs
Combination Drugs
Non-Insulin Injectable Drugs
Need A Different Region Or Segment?
Customize Now

South Africa Diabetes Drugs and Devices Market Size Summary

The South Africa diabetes drugs and devices market is poised for growth, driven by an increasing prevalence of diabetes and the rising adoption of advanced medical technologies. The market is experiencing a positive trajectory, influenced by factors such as the impact of COVID-19, which highlighted the importance of effective diabetes management due to its association with severe health outcomes. The prevalence of diabetes in South Africa is significant, with a substantial portion of the adult population affected, necessitating regular monitoring and management of blood glucose levels. The market is further bolstered by the growing incidence of Type 1 and Type 2 diabetes, largely attributed to lifestyle factors like obesity and physical inactivity. This has led to an increased demand for diabetes care products, including insulin delivery systems and continuous glucose monitoring devices, which are becoming more sophisticated and user-friendly.

Organizations such as Diabetes South Africa and SEMDSA play a crucial role in advocating for better diabetes care and supporting healthcare infrastructure. These entities, along with government initiatives like the sugar tax and Diabetes Prevention Program, aim to combat the rising diabetes rates by promoting healthier lifestyle choices and improving access to medical care. The market is characterized by continuous innovation, with major players investing in research and development to enhance product offerings and maintain competitive advantage. The introduction of new technologies, such as smartphone-integrated glucose monitors, is expected to make diabetes management more accessible and cost-effective. As a result, the South Africa diabetes drugs and devices market is anticipated to expand, driven by technological advancements, increased healthcare expenditure, and proactive public health measures.

Explore More

South Africa Diabetes Drugs and Devices Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Dynamics

      1. 1.2.1 Market Drivers

      2. 1.2.2 Market Restraints

    3. 1.3 Industry Attractiveness - Porter's Five Forces Analysis

      1. 1.3.1 Bargaining Power of Suppliers

      2. 1.3.2 Bargaining Power of Consumers

      3. 1.3.3 Threat of New Entrants

      4. 1.3.4 Threat of Substitute Products and Services

      5. 1.3.5 Intensity of Competitive Rivalry

  2. 2. Market Segmentation (Market Size by Volume - USD)

    1. 2.1 Devices

      1. 2.1.1 Monitoring Devices

        1. 2.1.1.1 Self-monitoring Blood Glucose Devices

        2. 2.1.1.2 Continuous Blood Glucose Monitoring

      2. 2.1.2 Management Devices

        1. 2.1.2.1 Insulin Pump

        2. 2.1.2.2 Insulin Syringes

        3. 2.1.2.3 Insulin Cartridges

        4. 2.1.2.4 Disposable Pens

    2. 2.2 Drugs

      1. 2.2.1 Oral Anti-Diabetes Drugs

      2. 2.2.2 Insulin Drugs

      3. 2.2.3 Combination Drugs

      4. 2.2.4 Non-Insulin Injectable Drugs

South Africa Diabetes Drugs and Devices Market Size FAQs

The South Africa Diabetes Drugs and Devices Market is projected to register a CAGR of greater than 2% during the forecast period (2024-2029)

Medtronics, Roche, NovoNordisk, Sanofi and Omnipod are the major companies operating in the South Africa Diabetes Drugs and Devices Market.

South Africa Diabetes Drugs and Devices Market Report Snapshots

South Africa Diabetes Drugs and Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)